Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
    84.
    发明授权
    Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies 失效
    使用拮抗性抗-CD40抗体治疗B细胞恶性肿瘤的方法

    公开(公告)号:US08088383B2

    公开(公告)日:2012-01-03

    申请号:US12891415

    申请日:2010-09-27

    IPC分类号: A61K39/395 C07K16/28

    摘要: Methods of therapy for B-cell malignancies are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity when the antibody binds a CD40 antigen on a normal human B cell, exhibits antagonist activity when the antibody binds a CD40 antigen on a malignant human B cell, and can exhibit antagonist activity when the antibody binds a CD40 antigen on a normal human B cell. Antagonist activity of the anti-CD40 antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of malignant human B cells.

    摘要翻译: 提供了B细胞恶性肿瘤治疗方法。 所述方法包括向有需要的患者施用治疗有效量的拮抗性抗CD40抗体或其抗原结合片段。 当抗体结合正常人B细胞上的CD40抗原时,拮抗性抗-CD40抗体或其抗原结合片段没有明显的激动剂活性,当抗体结合恶性人B细胞上的CD40抗原时,拮抗剂抗CD40抗体或其抗原结合片段, 当抗体结合正常人B细胞上的CD40抗原时,可以显示拮抗剂活性。 抗CD40抗体或其抗原结合片段的拮抗作用有益地抑制恶性人B细胞的增殖和/或分化。